Review Article

Roles of Dietary Bioactive Peptides in Redox Balance and Metabolic Disorders

Table 4

Molecular mechanisms of action of antihypertensive peptides isolated from various food sources.

Dietary protein sourceEnzyme used to produce peptidesPeptide sequence or molecular weightObjectIC50/EC50 valuesActivity/mechanisms of actionReference

Pea proteinThermolysin<3 kDaSHR and clinical trialPeptides (100 and 200 mg/kg BW) reduced SBP[140]
CaseinVPP and IPPClinical trialVPP and IPP improved central blood pressure and arterial stiffness[81]
Pistachio kernelPepsin and trypsinACKEPACE inhibition assayACE IC50 126 μMACKEP inhibited ACE by binding with ACE active site[88]
Chum salmon (Oncorhynchus keta) skinTrypsinGLPLNLPACE inhibition assay and SHRsACE IC50 18.7 μMGLP exhibited ACE inhibition and antihypertensive effect by decreasing SBP[94]
Skate (Okamejei kenojei) skinAlcalase and proteaseLGPLGHQ and MVGSAPGVLACE inhibition assay and SHRsACE IC50 3.09–4.22 μMPeptides inhibited ACE and decreased SBP and inhibited vasoconstriction via PPAR-γ expression, activation, and phosphorylation of eNOS in lungs[95]
Egg white ovotransferrinThermolysin and pepsinIQW and LKPSHRsPeptides reduced mean blood pressure[22]
Cuttlefish (Sepia officinalis) muscleCrude enzymes from B. mojavensis and cuttle fish hepatopancreasVELYP, AFVGYVLP, and EKSYELPACE inhibition assay and SHRsACE IC50 5.22 μMVELYP showed strong ACE inhibition through a noncompetitive inhibition and had antihypertensive effects by decreasing SBP[96]
Potato and rapeseedAlcalase and potato autolysisSLVSPSAAAAAAPGGS and KKRSKKKSFGGoldblatt rat with hypertension and ACE inhibitionACE IC50 324 μg/mL and 156 μg/mLPeptides inhibited ACE and exhibited antihypertensive effects by reducing SBP[85]
Rice bran proteinTrypsinYSKACE inhibition assayACE IC50 76 mMYSK showed ACE inhibition through the formation of hydrogen bonds with active pockets of human ACE[1]
Sipuncula (Phascolosoma esculenta)Pepsin and trypsinRYDF, YASGR and GNGSGYVSRACE inhibition assay and SHRsACE IC50 235 μM, 185 μM, and 29 μMThree peptides inhibited ACE noncompetitively. GNGSGYVSR (5 mg/kg BW) showed antihypertensive effect by decreasing SBP[97]
Lentil seeds (Lens culinaris var.)SavinaseLLSGTQNQPSFLSGF, NSLTLPILRYL, and TLEPNSVFLPVLLHACE inhibition assayACE IC50 44–120 μMInhibited ACE through interaction by hydrogen bonds with three ACE residues of the catalytic site[91]
Bighead carp musclePepsinYNLKERYAAW and YNRLPELACE inhibition assayACE IC50 1.35–3.42 μMPeptides inhibited ACE activity[98]
Bovine caseinPepsin and trypsinYQKFPQYLQYACE inhibition assay and SHRsACE IC50 11.1 μMPeptide inhibited ACE via competitive inhibition and exhibited antihypertension by decreasing SBP[82]
Hazelnut (Corylus heterophylla Fisch.)AlcalaseAVKVL, YLVR, and TLVGRACE inhibition assay and SHRsACE IC50 15.42–249.3 μMPeptides inhibited ACE activity via a noncompetitive mode via the formation of cation–pi interactions and YLVR reduced SBP[89]
Egg white from ostrichAlkaline hydrolysisYVACE inhibition assayACE IC50 63.97 μg/mLYV showed ACE inhibition by binding to S1 and S2 ACE pocket sites via hydrogen bonds[93]
SoybeanPediococcus pentosaceus SDL1409EDEVSFSP, SRPFNL, RSPFNL, and ENPFNLACE inhibition assayACE IC50 0.131–0.811 mg/mLPeptides inhibited ACE via essential N-terminal sequence and amino acid position[84]
Shrimp (Pandalus borealis) proteinRandomized, double-blind, placebo-controlled, 8-week clinical studyPeptides (1200 mg/d) reduced the blood pressure due to a reduction of angiotensin II levels[79]
Beef (Bos taurus coreanae) myofibrillar proteinsAlkaline-AK and papainLIVGIIRCVACE inhibition assay and SHRsPeptides (400 and 800 mg/kg BW) inhibited ACE by 74.29% and decreased SBP[99]
MilkFermented using L. delbrueckii QS306LPYPYACE inhibition assayACE IC50 12.87 μg/mLLPYPY inhibited ACE with IC50 12.87 μg/mL[80]
Mung bean proteinBromelainLPRL, YADLVE, LRLESF, HLNVVHEN, and PGSGCAGTDLACE inhibition assay and SHRsACE IC50 5.39–1912 μMPeptides showed ACE inhibition and reduced SBP[90]
Seahorse (Hippocampus abdominalis)ProtamexAPTL, CNVPLSP, and PWTPLACE inhibition assay and SHRsACE IC50 0.044 μMPeptides exhibited antihypertension by lowering blood pressure via vasodilation and ACE inhibition[92]
Black cumin seedα-ChymotrypsinVTPVGVPKACE inhibition assayACE IC50 value 1.8 μMVTPVGVPK inhibited ACE via a noncompetitive inhibition[86]
Quinoa proteinChymotrypsinQHPHGLGALCAAPPSTACE inhibition assayPeptide displayed ACE inhibition by binding to ACE active hotspots[62]
White turmeric, turmeric, and ginger proteinsPepsin and trypsinVTYM, RGPFH, AEPPR, GSGLVP, KM, SPV, CACGGV, DVDP, CGVGAA, HVVV, and RSCACE inhibition assayACE IC50 16.4–36.5 μMPeptides showed ACE inhibition[9]
Coix prolaminPepsinVDMFACE inhibition assayACE IC50 382.28 μMVDMF reduced ACE and AT1R expression in AngII-injury HUVECs[87]
Wheat glutenAlcalase and PaproASAGGYIW and APATPSFWACE inhibition assayACE IC50 0.002–0.036 mg/mLPeptides and negatively charged amino acids inhibited ACE via modulating ionic and hydrophobic interactions on ACE catalytic sites[83]

ACE: angiotensin-converting enzyme; BW: body weight; IC50: 50% inhibitory concentration; SBP: systolic blood pressure; SHR: spontaneously hypertensive rat; PPAR-γ: peroxisome proliferator-activated receptor γ.